论文部分内容阅读
目的分析比较肾上腺素联合喘可治雾化吸入治疗婴幼儿毛细支气管炎的效果。方法 64例喘息患者随机分为两组,治疗组38例,对照组26例。对照组给予常规抗感染、镇静、吸氧、祛痰对症支持治疗基础上,给予沙丁胺醇、布地奈德雾化吸入,1次/8 h;治疗组在对照组基础治疗上改用肾上腺素联合喘可治氧驱动雾化吸入,1次/8 h。结果治疗组患者在临床症状的消失时间及住院总时间(6.14±0.92)d的比较上,优于对照组临床症状消失时间及住院总时间(8.12±1.21)d,组间比较差异有统计学意义(P<0.05)。结论肾上腺素联合喘可治氧驱动雾化吸入治疗婴幼儿毛细支气管炎疗效可靠,值得临床推广。
Objective To compare the effect of epinephrine and chuankezhi nebulization in the treatment of infantile bronchiolitis. Methods Sixty-six wheezing patients were randomly divided into two groups: treatment group (38 cases) and control group (26 cases). The control group was given conventional anti-infective, sedative, oxygen, expectorant symptomatic and supportive treatment based on the administration of salbutamol, budesonide inhalation, 1/8 h; the treatment group in the control group on the use of epinephrine combined with asthma Oxygen-driven aerosol inhalation, 1/8 h. Results Compared with the control group, the disappearance time of clinical symptoms and the total length of hospital stay (6.14 ± 0.92) d in the treatment group were significantly better than those in the control group (8.12 ± 1.21) d, the difference was statistically significant Significance (P <0.05). Conclusion Epinephrine combined with asthma can promote aerosol inhalation treatment of infant bronchiolitis is reliable and worthy of clinical promotion.